Skip to content

Drug interactions

Netupitant-palonosetron + Olaparib

Severity: Major

Netupitant-palonosetron and Olaparib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Netupitant may increase olaparib exposure via CYP3A inhibition, raising the risk of anemia, nausea and other adverse effects.

What this interaction means in plain words

Netupitant-palonosetron and Olaparib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Netupitant-palonosetron belongs to Gastrointestinal Tract; Olaparib belongs to Oncology.

Evidence level: Moderate

Why it happens

Netupitant inhibits CYP3A4, reducing olaparib metabolism.

What to do

Avoid if possible. If unavoidable, reduce the olaparib dose per labeling and monitor blood counts.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Netupitant-palonosetron and Olaparib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Netupitant-palonosetron with Olaparib?

MediHelp rates the interaction as major. Netupitant-palonosetron and Olaparib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Netupitant may increase olaparib exposure via CYP3A inhibition, raising the risk of anemia, nausea and other adverse effects.

How serious is the interaction between Netupitant-palonosetron and Olaparib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible. If unavoidable, reduce the olaparib dose per labeling and monitor blood counts.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in